23andMe GWAS Study in Nature Identifies GLP1R Genetic Variant Predicting Extra Weight Loss
A large GWAS study published in Nature identified a missense variant in GLP1R predicting an additional 0.76 kg of weight loss per allele copy. GIPR variation was linked to nausea/vomiting side effects specific to tirzepatide users.